Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

By Elias Schisgall


Amazon said it would invest $5 billion in Anthropic, with the potential for up to $20 billion more based on commercial milestones. Anthropic also committed to spend upward of $100 billion on Amazon technologies over the next ten years. Shares gained 2.6% to $254.80 in after-hours trading Monday.

Alaska Air Group withdrew its guidance, citing uncertainty around the cost of fuel from the war in Iran. Shares fell 4.9% to $41.40 after the bell.

BridgeBio Oncology Therapeutics received fast-track designation from the Food and Drug Administration for its pancreatic cancer treatment. Shares were up 4.2% to $9.65.

AXT disclosed plans to sell shares in a secondary offering. The stock declined 12% to $69.25.


Write to Elias Schisgall at elias.schisgall@wsj.com


(END) Dow Jones Newswires

April 20, 2026 19:10 ET (23:10 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center